Metabolism of inorganic arsenic in intestinal epithelial cell lines

Chemical Research in Toxicology

Volumn 25, Issue 11, 2012, Pages 2402-2411

  Calatayud, M ^a   Velez D ^a   Devesa, V ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ARSENIC DERIVATIVE; DIPEPTIDYL PEPTIDASE IV; MESSENGER RNA; OLIGONUCLEOTIDE; SUCRASE ISOMALTASE;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL METABOLISM; CELL STRAIN CACO 2; CELL VIABILITY; IN VITRO STUDY; INTESTINE; INTESTINE EPITHELIUM CELL; NUCLEOTIDE SEQUENCE; OXIDATION; PROTEIN EXPRESSION;

ARSENIC; CACO-2 CELLS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HT29 CELLS; HUMANS; INTESTINE, SMALL; METHYLTRANSFERASES; RNA, MESSENGER; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84869439156     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx300385y     Document Type: Article

References (57)

1. EFSA (2009) Panel on Contaminants in the Food Chain (CONTAM); scientific opinion on arsenic in food EFSA J. 7 (10) 1351
2. JEFCA (2010) Joint FAO/WHO Expert Committee on Food Additives, Summary Report of the Seventy-Second Meeting of JECFA, JECFA/72/SC, Rome, http://www.who.int/foodsafety/chem/summary72-rev.pdf
3. IARC (2004) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs, Vol. 84, p 39, International Agency for Cancer Research, Lyon, France.
4. Kojima, C., Ramirez, D. C., Tokar, E. J., Himeno, S., Drobná, Z., Stýblo, M., Mason, R. P., and Waalkes, M. P. (2009) Requirement of arsenic biomethylation for oxidative DNA damage J. Natl. Cancer Inst. 101, 1670-1681
5. Thomas, D. J., Li, J., Waters, S. B., Xing, W., Adair, B. M., Drobná, Z., Devesa, V., and Stýblo, M. (2007) Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals Exp. Biol. Med. 232, 3-13
6. Stýblo, M., Vega, L., Germolec, D. R., Luster, M. I., Del Razo, L. M., Wang, C., Cullen, W. R., and Thomas, D. J. (1999) Metabolism and toxicity of arsenicals in cultured cells, in: Chappell, W., Abernathy, C. O., and Calderon, R. L., Eds. Arsenic Exposure and Health Effects, pp 311-334, Elsevier Science, Ltd., UK.
7. Naranmandura, H., Carew, M. W., Xu, S., Lee, J., Leslie, E. M., Weinfeld, S. M., and Le, X. C. (2011) Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 Cells Chem. Res. Toxicol. 24, 1586-1596
8. Dopp, E., von Recklinghausen, U., Diaz-Bone, R., Hirner, A. V., and Rettenmeier, A. W. (2010) Cellular uptake, subcellular distribution and toxicity of arsenic compounds in methylating and non-methylating cells Environ. Res. 110, 435-442
9. Stýblo, M., Del Razo, L. M., Vega, L., Germolec, D. R., LeCluyse, E. L., Hamilton, G. A., Reed, W., Wang, C., Cullen, W. R., and Thomas, D. J. (2000) Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells Arch. Toxicol. 74, 289-299
10. Sakurai, T., Kojima, C., Kobayashi, Y., Hirano, S., Sakurai, M. H., Waalkes, M. P., and Himeno, S. (2006) Toxicity of a trivalent organic arsenic compound, dimethylarsinous glutathione in a rat liver cell line (TRL 1215) Br. J. Pharmacol. 149, 888-897
11. Drobná, Z., Xing, W., Thomas, D. J., and Stýblo, M. (2006) shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells Chem. Res. Toxicol. 19, 894-898
12. Drobná, Z., Waters, S. B., Devesa, V., Harmon, A. W., Thomas, D. J., and Stýblo, M. (2005) Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase Toxicol. Appl. Pharmacol. 207, 147-159
13. Buchet, J. P. and Lauwerys, R. (1985) Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man Arch. Toxicol. 57, 125-129
14. Del Razo, L. M., Stýblo, M., Cullen, W. R., and Thomas, D. J. (2001) Determination of trivalent methylated arsenicals in biological matrices Toxicol. Appl. Pharmacol. 174, 282-293
15. Drobná, Z., Waters, S. B., Walton, F. S., LeCluyse, E. L., Thomas, D. J., and Stýblo, M. (2004) Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes Toxicol. Appl. Pharmacol. 201, 166-177
16. Drobná, Z., Walton, F. S., Harmon, A. W., Thomas, D. J., and Stýblo, M. (2010) Interspecies differences in metabolism of arsenic by cultured primary hepatocytes Toxicol. Appl. Pharmacol. 245, 47-56
17. Watanabe, T., Ohta, Y., Mizumura, A., Kobasyashi, Y., and Hirano, S. (2011) Analysis of arsenic metabolites in HepG2 and AS·MT-transfectes cells Arch. Toxicol. 85, 577-588
18. Lin, J. H., Chiba, M., and Baillie, T. A. (2011) Is the role of the small intestine in first-pass metabolism overemphasized? Pharmacol. Rev. 51, 135-157
19. Calatayud, M., Gimeno, J., Vélez, D., and Devesa, V. (2010) Characterization of the intestinal absorption of arsenate, monomethylarsonic acid, and dimethylarsinic acid using the Caco-2 cell line Chem. Res. Toxicol. 23, 547-556
20. Calatayud, M., Devesa, V., Montoro, R., and Vélez, D. (2011) In vitro study of intestinal transport of arsenite, monomethylarsonous acid, and dimethylarsinous acid by Caco-2 cell line Toxicol. Lett. 204, 127-133
21. Mahler, G. J., Shuler, M. L., and Glahn, R. P. (2009) Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability J. Nutr. Biochem. 20, 494-502
22. Devesa, V., Del Razo, L. M., Adair, B., Drobná, Z., Waters, S. B., Hughes, M. F., Stýblo, M., and Thomas, D. J. (2004) Comprehensive analysis of arsenic metabolites by pH specific hydride generation atomic absorption spectrometry J. Anal. At. Spectrom. 19, 1460-1467
23. Lesuffleur, T, Porchet, N, Aubert, J. P., Swallow, D, Gum, J. R., Kim, Y. S., Real, F. X., and Zweibaum, A. (1993) Differential expression of the human mucin genes Muc1 to Muc5 in relation to growth and differentiation of different mucus-secreting Ht-29 cell aubpopulations J. Cell. Sci. 106, 771-783
24. Ferruzza, S., Rossi, C., Scarino, M. L., and Sambuy, Y. (2011) A protocol for in situ enzyme assays to assess the differentiation of human intestinal Caco-2 cells Toxicol. in Vitro 10.1016/j.tiv.2011.11.007.
25. Hashimoto, K. and Shimizu, M. (1993) Epithelial properties of human intestinal Caco-2 cells cultured in a serum-free medium Cytotechnology 13, 175-184
26. Wang, S. and Evers, B. M. (1999) Caco-2 cell differentiation is associated with a decrease in stat protein levels and binding J. Gastrointest. Surg. 3, 200-207
27. Forstner, G. (1994) Gastrointestinal Mucus, Physiology of the Gastrointestinal Tract, 3 rd ed., pp 1255-1283, Raven Press, New York.
28. Juhasz, A. L., Smith, E., Weber, J., Rees, M., Rofe, A., Kuchel, T., and Sansom, L. (2006) In vivo assessment of arsenic bioavailability in rice and its significance for human health risk assessment Environ. Health Perspect. 12, 1826-1831
29. Juhasz, A. L., Smith, E., Weber, J., Rees, M., Rofe, A., Kuchel, T., Sansom, L., and Naidu, R. (2008) Application of an in vivo swine model for the determination of arsenic bioavailability in contaminated vegetables Chemosphere 71, 1963-1969
30. 3-induced oxidative stress and cycle progression in a human intestinal epithelial cell line (Caco-2) Toxicol. in Vitro 22, 444-449
31. Stýblo, M., Del Razo, L. M., LeCluyse, E. L., Hamilton, G. A., Wang, G., Cullen, W. R., and Thomas, D. J. (1999) Metabolism of arsenic in primary cultures of human and rat hepatocytes Chem. Res. Toxicol. 12, 560-565
32. Hirano, S., Cui, X., Li, S., Kanno, S., Kobayashi, Y., Hayakawa, T., and Shraim, A. (2003) Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells Arch. Toxicol. 77, 305-312
33. Stýblo, M., Serves, S. V., Cullen, W. R., and Thomas, D. J. (1997) Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols Chem. Res. Toxicol. 10, 27-33
34. Lin, S., Cullen, W. R., and Thomas, D. J. (1999) Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase Chem. Res. Toxicol. 12, 924-930
35. Matsumoto, H., Erickson, R. H., Gum, J. R., Yoshioka, M., Gum, E., and Kim, Y. S. (1990) Biosynthesis of alkaline-phosphatase during differentiation of the human colon cancer cell-line Caco-2 Gastroenterology 9, 1199-1207
36. Jumarie, C. and Malo, C. (1991) Caco-2 cells cultured in serum-free medium as a model for the study of enterocytic differentiation in vitro J. Cell Physiol. 149, 24-33
37. Sonoyama, K., Suzuki, K., and Kasai, T. (2000) Peptide YY stimulates the expression of apolipoprotein A-IV gene in Caco-2 intestinal cells Proc. Soc. Exp. Biol. Med. 223, 270-275
38. Fleet, J. C., Eksir, F., Hance, K. W., and Wood, R. J. (2002) Vitamin D-inducible calcium transport and gene expression in three Caco-2 cell lines Am. J. Physiol-Gastrointest. Liver Physiol. 283, G618-G25
39. Bédrine-Ferran, H., Le Meur, N., Gicquel, I., Le Cunff, M., Soriano, N., Guisle, I., Mottier, S., Monnier, A., Teusan, R., Fergelot, P., Le Gall, J.-Y., Léger, J., and Mosser, J. (2004) Transcriptome variations in human CaCo-2 cells: a model for enterocyte differentiation and its link to iron absorption Genomics 83, 772-789
40. Siissalo, S., Hannukainen, J., Kolehmainen, J., Hirvonen, J., and Kaukonen, A. M. (2009) A Caco-2 cell based screening method for compounds interacting with MRP2 efflux protein Eur. J. Pharm. Biopharm. 71, 332-338
41. Calatayud, M., Barrios, J. A., Vélez, D., and Devesa, V. (2012) In vitro study of transporters involved in intestinal absorption of inorganic arsenic Chem. Res. Toxicol. 25, 446-453
42. König, J., Seithel, A., Gradhand, U., and Fromm, M. F. (2006) Pharmacogenomics of human OATP transporters Naunyn-Schmiedeberg's Arch. Pharmacol. 372 (6) 432-43
43. Mahraoui, L., Rousset, M., Dussaulx, E., Darmoul, D., Zweibaum, A., and Brot-Laroche., E. (1992) Expression and localization of GLUT-5 in Caco-2 cells, human small intestine, and colon Am. J. Physiol. Gastrointest. Liver Physiol. 263, G312-G318
44. Fleet, J. C., Wang, L. Y., Vitek, O., Craig, B. A., and Edenberg, H. J. (2003) Gene expression profiling of Caco-2 BBe cells suggests a role for specific signaling pathways during intestinal differentiation Physiol. Genomics. 13 (1) 57-68
45. Landowski., C. P., Anderle, P., Sun, D. X., Sadee, W., and Amidon, G. L. (2004) Transporter and ion channel gene expression after Caco-2 cell differentiation using 2 different microarray technologies AAPS J. 6 (3) 35-44
46. Waters, S. B., Devesa, V., Del Razo, L. M., Stýblo, M., and Thomas, D. J. (2004) Endogenous reductants support the catalytic function of recombinant rat cyt19, an arsenic methyltransferase Chem. Res. Toxicol. 17, 404-409
47. Waters, S. B., Devesa, V., Fricke, M. W., Creed, J., Stýblo, M., and Thomas, D. J. (2004) Glutathione modulates recombinant rat arsenic (+3 oxidation state) methyltransferase-catalyzed formation of trimethylarsine oxide and trimethylarsine Chem. Res. Toxicol. 17, 1621-1629
48. Gaillard, J. L. and Finlay, B. B. (1996) Effect of cell polarization and differentiation on entry of Listeria monocytogenes into the enterocyte-like Caco-2 cell line Infect. Immun. 64, 1299-1308
49. Anderle, P., Rakhmanova, V., Woodford, K., Zerangue, N., and Sadee, W. (2003) Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines Pharm. Res. 20 (1) 3-15
50. Fuller, S. D. and Simons, K. (1986) Transferrin receptor polarity and recycling accuracy in tight and leaky strains of madin-darby canine kidney-cells J. Cell Biol. 103, 1767-1779
51. Ferriola, P. C., Cody, V., and Middleton, E. (1989) Protein-Kinase C inhibition by plant flavonoids: kinetic mechanisms and structure-activity- relationships Biochem. Pharmacol. 38, 1617-1624
52. Agullo, G., Gamet-Payrastre, L., Manenti, S., Viala, C., Rémésy, C., Chap, H., and Payrastre, B. (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition Biochem. Pharmacol. 53, 1649-1657
53. Vahter, M. (2007) Interactions between arsenic-induced toxicity and nutrition in early life J. Nutr. 137, 2798-2804
54. Heck, J. E., Gamble, M. V., Chen, Y., Graziano, J. H., Slavkovich, V., Parvez, F., Baron, J. A., Howe, G. R., and Ahsan, H. (2007) Consumption of folate-related nutrients and metabolism of arsenic in Bangladesh Am. J. Clin. Nutr. 85, 1367-1374
55. Hall, M. N., Liu, X. H., Slavkovich, V., Ilievski, V., Mi, Z. Y., Alam, S., Factor-Litvak, P., Ahsan, H., Graziano, J. H., and Gamble, M. V. (2009) Influence of cobalamin on arsenic metabolism in Bangladesh Environ. Health Perspect. 117, 1724-1729
56. Leslie, E. M., Haimeur, A., and Waalkes, M. P. (2004) Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a triglutathione conjugate is required J. Biol. Chem. 279, 32700-32708
57. Lesuffleur, T., Barbat, A., Dussaulx, E., and Zweibaum, A. (1990) Growth adaptation to methotrexate of HT-29 human colon-carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells Cancer Res. 50, 6334-6343